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Abstract.  Renal cells contain two corticosteroid- 
binding entities defined on the basis of hormone-bind- 
ing selectivity as type I  (mineralocorticoid) and type II 
(glucocorticoid). The mineralocorticoid, aldosterone 
can bind to both type I and type II receptors.  This 
poses problems in defining the characteristics of a true 
mineralocorticoid regulated expression of specific 
genes. We have used chimaeric constructs bearing the 
mouse mammary tumor virus (MMTV) promoter to 
study aldosterone action in the feline renal cell line 
CRFK. We have shown that in these cells aldosterone 
induces MMTV transcription through its own receptor 
(type I).  This induction of MMTV transcription by al- 
dosterone is a primary response to the hormone. We 
have shown that the DNA sequences that mediate the 
aldosterone response overlap the hormone response 
element (HRE) required for the glucocorticoid, 
progestin, and androgen induction of transcription at 
the MMTV long terminal repeat region.  Thus the al- 
dosterone regulation of MMTV long terminal repeat 
transcription is identical to the mode of action of the 
other steroid hormones at this promoter. 
T 
HE steroid hormones that constitute the class corti- 
costeroids are glucocorticoids and mineralocorticoids. 
Glucocorticoids  regulate  many  developmental  pro- 
cesses in higher eukaryotes and play an important role in cel- 
lular metabolism (for review see reference 7). Mineralocor- 
ticoids  on  the  other  hand  promote  sodium  reabsorption 
across tight epithelia such as in the colon or in the distal 
nephron (22). Whilst the physiological function of glucocor- 
ticoids in the regulation of the expression of a number of 
genes have been intensively studied (for reviews see refer- 
ences 3 and 32), little information is available on the effect 
of mineralocorticoids on the expression of specific genes. 
One reason for this lack of information on mineralocorticoid 
action  is  the  difficulty involved  in  distinguishing a  true 
mineralocorticoid from a glucocorticoid response. Aldoster 
one, the available mineralocorticoid that can be used in tran- 
scriptional studies has a low but significant affinity for the 
glucocorticoid receptor (19). Similarly glucocorticosteroids 
also interact with the mineralocorticoid receptor (19). 
One way of studying a true mineralocorticoid induction of 
specific gene transcription is to transfect the cloned miner- 
alocorticoid receptor and a marker gene into cells that do not 
contain mineralocorticoid or glucocorticoid receptors. Such 
an approach has been used by Arriza et al. (1987) (1) to show 
that mineralocortiocids induce mouse mammary tumor virus 
long terminal repeat (MMTV LTR)  j transcription. Another 
approach is to use a mineralocorticoid antagonist in cells that 
1. Abbreviations used in this paper: HRE, hormone response element; LTR, 
long terminal repeat; MMTV, mouse mammary tumor virus. 
contain corticosteroid receptors to determine which changes 
in gene expression could be attributed to the effect of the 
mineralocorticoid hormone. 
In this report, we have investigated the effect of aldosterone 
on the transcription at the MMTV LTR promoter in the fe- 
line kidney cell line (CRFK) that contains both mineralocor- 
ticoid  and  glucocorticoid receptors.  With  the  aid  of the 
mineralocorticoid antagonist RU28318 (17 13-hydroxy-3-oxo, 
7  a-propyl (17  ct)-pregn  4-ene,  21  potassium carboxylate) 
(21), we have shown that aldosterone induces MMTV LTR 
transcription in these cells via the mineralocorticoid recep- 
tor. As in the case of the induction of MMTV LTR transcrip- 
tion by other classes of steroid hormones, sequences in the 
hormone response element (HRE) of the MMTV LTR play 
an important role in the aldosterone response. We have there- 
fore identified the HRE as an important regulatory element 
for the mineralocorticoid induction of MMTV LTR tran- 
scription. 
Materials and Methods 
Hormones and Anti-Hormones 
Non-radioactive  dexamethasone  and  aldosterone  were  purchased  from 
Sigma Chemical Co. (St. Louis, MO). [1,2,4,6,7,-3H]Dexamethasone 78.7 
Ci/mmol  and  [1,2-3H]aldosterone  49  Ci/mmol  were  purchased  from 
Amersham. The synthetic glucorticoid RU28362 and the mineralocorticoid 
antagonist RU28318 were supplied by Roussel Uclaf (Romainville, France). 
Construction of Plasmids 
Plasmid pGR102 is an endogenous-exogenous hybrid provirus constructed 
from the plasmids pGR20 and pGR21  as previously described (23). 
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MMTV LTR sequences (-631/+125) linked to the CAT gene as previously 
described (4). 
Plasmid pHC9 contains MMTV LTR sequences (-428/+125) linked to 
the CAT gene. This plasmid was constructed by substituting the Hind III/Sst 
I MMTV LTR fragment (-631/-102) of pMMTVCAT with the HindlII/Sst 
I MMTV LTR fragment (-428/-102) of ptkCAT5A  (4). 
Plasmid pHCwt contains MMTV LTR sequences (-237/+125) linked to 
the CAT gene. This plasmid was constructed by substituting the Bam HI/Bst 
Eli MMTV LTR fragment (-631/+110) of pMMTV CAT (4) with the Bam 
HI/Bst EII fragment (-237/+110)  of p.2.6 (10). 
Plasmid pGREOOCAT  contains MMTV  LTR  sequences (-73/+125) 
linked to the CAT gene. This plasmid was constructed by the removal of the 
Barn  HI/Bam  HI  MMTV  LTR  fragment  (-631/-73)  of the  construct 
psBsl.CAT (14). 
Cell Culture and Transfection of  Cells 
A  cloned population of feline kidney cells (designated 2C9)  stably co- 
transfected with the construct pGR102  and pSV2r~  as described by (25) 
was cultured in DME supplemented with 3 % FCS, stripped of hormone by 
charcoal treatment (CCS) (31). Transient transfection with these cells was 
carried out using the calcium phosphate method as described by (16). For 
transient transfection, the cells were cultured in DME supplemented with 
10%  FCS,  and treated with "low" concentration (10  -6 M) of the miner- 
alocorticoid antagonist RU28318 for 24 h before and all through the transfec- 
tion procedure. Cells treated with hormone were given 10-6 M aldosterone 
in addition to the 10  -6 M RU28318. This concentration of aldosterone over- 
comes the effect of the antagonist. The cells were treated with the antagonist 
to reduce the basal level of mineralocorticoids in the culture medium. 
CAT Assay 
CAT assay with cellular extracts of transfected 2C9 cells was performed as 
previously described (4). 
Hormone Receptor Measurements 
Steroid hormone receptor levels in cytosol of 2C9 cells was determined in 
duplicates by the dextran-coated charcoal procedure (2). The cytosol was 
incubated with radioactive ligands for 24 h at 4°C. For aldosterone receptor 
measurements, saturating concentrations of [3H]aldosterone  (10 nM) with 
RU28362 (1 p.M) were used and the binding of the radioactive aldosterone 
was displaced by 1 IxlVI unlabeled aldosterone. For glucocorticoid receptor 
measurements,  saturating  concentration of [3H]dexamethasone (10  nM) 
was used and binding to the receptor was displaced by  1 IxM RU28362. 
$1 Nuclease Mapping 
S1 nuclease mapping experiments with RNA extracted from 2C9 cells were 
carried out as described by (29). For mapping the start of transcription at 
the MMTV LTR promoter a 2.1  kb Cla I/Hpa II fragment from plasmid 
p.2.6 (10) was used. Transcripts initiated at the SV40 promoter of the co- 
transfected pSV2,~o plasmid (25)  were mapped using a 3.0-kb  Eco RI/Bgl 
II fragment of the pSV2neo  construct as probe. 
Results 
The Feline Kidney Cell Line CRFK Contains Both 
Mineralocorticoid and Glucocorticoid Receptors 
We have used the feline (Felis catus) renal cell line CRFK 
(16) that had  been co-transfected with  an endogenous-ex- 
ogenous hybrid MMTV  proviral DNA (23) and the plas- 
mid pSVE.eo (25)  to  study the  regulation of MMTV  LTR 
transcription by mineralocorticoids. A cloned population of 
the transfected CRFK cells designated 2C9 (23) was chosen 
for these studies. 
The mineralocorticoid receptor level in these 2C9 cells 
was  measured as  14.9  _+ 0.5 f moles/mg protein using the 
dextran-charcoal-coated  method  (2).  In  these  measure- 
ments, a mixture of [3H]aldosterone and 100-fold excess of 
unlabeled glucocorticoid, RU28362  (1113, 17~dihydroxy-6- 
methyl-17a-(1-propynyl)-androsta-l,4,6,-trien-3-one)  (20) was 
used  as  radioactive ligand.  RU28362 prevents  [3H]aldos- 
terone from binding  to the glucocorticoid receptor as  al- 
dosterone has some affinity for this receptor (19). RU28362 
itself has  a  high  affinity  for  the  glucocorticoid receptor 
but virtually no affinity for the mineralocorticoid receptor 
(19).  The  combination  of  [3H]aldosterone and  unlabeled 
RU28362  in  the  rec~eptor determination  protocol  would 
ensure  measurements  of only  mineralocorticoid  receptor 
levels. To calculate the level of binding of the labeled al- 
dosterone to the mineralocorticoid receptor, 100-fold excess 
unlabeled aldosterone was added in some experiments. The 
binding of [3H]aldosterone to its binding entity in the cyto- 
solic extracts of the feline kidney cells was  saturated by 10 
nM. The level of binding was identical whether labeled al- 
dosterone was used alone or in combination with RU28362. 
This indicates that under the conditions used aldosterone was 
only interacting with  the  mineralocorticoid receptor. The 
2C9 cells also contain glucocorticoid receptor which was 
measured as 131.8 +  20.4 fmol/mg protein using [3H]dexa- 
methasone as radioactive ligand and RU28362 to displace 
the labeled dexamethasone specifically bound to the gluco- 
corticoid receptor. No measurable levels of progesterone or 
androgen receptors were determined in these cells (data not 
shown). 
A ldosterone Induces the Transcription of Transfected 
Chimaeric MMTV LTR Proviral DNA in the 
Feline Kidney Cell Line CFRK 
The 2C9 cells were cultured in medium supplemented with 
FCS that had previously been stripped of hormone (CCS) ac- 
cording to the method of (31). These cells were then treated 
for  16  h  with  different concentrations of aldosterone and 
RNAs were extracted and analyzed by the S1 nuclease map- 
ping procedure. 
S1 nuclease mapping studies with RNAs from cells cul- 
tured in medium supplemented with untreated serum showed 
a high level of MMTV LTR transcription even in the absence 
of added aldosterone. Although medium supplemented with 
10% CCS reduced this level of MMTV LTR transcription, 
an even lower basal level was obtained when the cells were 
cultured in medium containing 3 % CCS. Alternatively this 
basal activity of the MMTV LTR promoter could be lowered 
by treating the cells with the mineralocorticoid inhibitor RU- 
28318.  This indicates that FCS contains mineralocorticoid 
agonists that could induce transcription at the MMTV LTR 
promoter even in the absence of added aldosterone. Similar 
data have already been obtained by Arriza et al.  (1). 
In the S1 nuclease mapping experiments with RNA from 
2C9 cells cultured for a week in medium supplemented with 
3 % CCS, we observed that the correct start of transcription 
was  used at the  3TIMTV LTR promoter.  The amount of 
RNA initiated at this site was increased dose dependently by 
aldosterone (Fig.  1 B, lanes 1-5). As slight differences may 
exist in the amounts of RNA used for these studies, we used 
as an internal control the amount of transcript initiated at the 
hormone insensitive SV40 promoter (Fig. 1 C, lanes 1-5) to 
standardize the calculation of the relative intensity of the SI 
nuclease signals.  We achieved this by scanning the bands 
corresponding to the correctly initiated MMTV  LTR and 
SV40 transcripts (see arrows in Fig. 1, B and C) and express- 
ing them as a ratio of the MMTV LTR band over the SV40 
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concentration of aldosterone used in the experiment (Fig.  1 
D).  From this graph, we calculated the concentration of al- 
dosterone  required  for half maximal  induction  of MMTV 
LTR transcription. This value (7 nM) is close to the dissocia- 
tion constant of aldosterone for the mineralocorticoid recep- 
tor measured in brain and pituitary cells of the rat (15) and 
in the 2C9 cells (Kd  =  3 nM) (results  not shown). Thus the 
induction of MMTV LTR transcription  by aldosterone oc- 
curs most likely through the mineralocorticoid receptor. 
Hormone Specificity 
To  investigate  whether  the  aldosterone  response  is  indeed 
mediated by the mineralocorticoid receptor, the effect of the 
mineralocorticoid antagonist,  RU28318 on the aldosterone- 
induced MMTV LTR transcription  was studied.  As a  con- 
trol, the effect of RU28318 on glucocorticoid induced MMTV 
LTR transcription was also studied.  The induction of MMTV 
LTR transcription  by  10  -7  M  aldosterone  was dose depen- 
dently inhibited by RU28318 (Fig. 2).  RU28318 (with an an- 
tagonist/agonist molar ratio of 100)  inhibits  65%  of the al- 
dosterone induced MMTV LTR transcription. Transcription 
at the MMTV LTR promoter induced by 10  -7 M  dexameth- 
asone  was  not  affected  by  any  of  the  concentrations  of 
RU28318 tested  (10-  8 to  10  -5 M)  (Fig.  2). 
Taken together,  these results confirm published  data that 
RU28318 interacts weakly but virtually only with the miner- 
alocorticoid receptor (21).  Our results also demonstrate that 
the aldosterone induction of MMTV LTR transcription in the 
Figure  1.  Aldosterone induces transcription  at the 
MMTV LTR promoter of a transfected  chimaeric 
proviral  DNA in feline kidney cells.  (A) 2C9 cells 
are a cloned population of feline kidney cells  co- 
transfected  with  a  chimaeric endogenous-exoge- 
nous  MMTV  LTR  construct  pGRI02  (23)  and 
pSV2,eo (25).  Transcripts  derived from the 3' LTR 
of the pGR102 construct were mapped using an SI 
'mclease  mapping procedure  with  a  2.l-kb  Cla 
I/Hpa II fragment from plasmid p 2.6 (10) labeled 
at  the 5' end  of the Hpa II site.  Correctly initi- 
ated transcripts  protect a  106 nucleotide  fragment 
of  this probe. Transcripts  originating at the correct 
SV40 promoter of the co-transfected  pSV2n¢o con- 
struct  protect  392  nucleotides  of a  3.0-kb  Eco 
RI/Bgl II probe labeled  at the 5' end at the Bgl II 
site.  The open bar of pGR102 represents  the en- 
dogenous  5'  LTR  and  gag  sequences  and  the 
striped  bar represents  the 3' exogenous  LTR and 
env,  sequences  (23).  The  broken  lines  in  the 
pSV2.eo construct  represent  pBR322  sequences. 
The probes and RNA transcripts  have been indi- 
cated.  (B and C) 30 ~tg RNAs derived  from 2C9 
cells  cultured  1 wk in DME supplemented  with 
3%  hormone-stripped  FCS  (CCS)  and  treated 
with  the  indicated  concentrations of aldosterone 
(Aid) were used in the S1 nuclease mapping proce- 
dure.  The 2.l-kb Cal l/Hpa II fragment of p.2.6 
(10)  and  the  3.0-kb  Eco  RI/BglII  fragment  of 
pSV2.~o (23)  were used  as probes for the S1  nu- 
clease mapping experiments.  The arrows in B and 
C show the correct MMTV LTR start of transcrip- 
tion and the correct start  of transcription  at the 
SV40 promoter. M represents  labeled Hae III frag- 
ments of pBR322  used as marker.  (D) The bands 
in the SI nuclease  autoradiographs corresponding 
to  the  106  and  392  nucleotide  fragments  were 
scanned and plotted as a ratio of  the intensity of the 
106nt fragment over the 392nt fragment against the 
concentration of aldosterone. 
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Figure  2. The mineralocorticoid antagonist RU28318 inhibits the al- 
dosterone but not the dexamethasone-induced transcription at the 
MMTV LTR promoter. 30 ~tg of RNA from 2C9 cells treated with 
10  -7 M aldosterone or 10  -7 M dexamethasone and each with the 
indicated concentrations of RU28318 were used for S1  nuclease 
mapping with the 2.1-kb MMTV LTR probe and the 3.0 kb SV40 
probe. The graphs show the intensity of the MMTV LTR 106nt S1 
nuclease fragment over the SV40 392nt S1 nuclease fragment ex- 
pressed  in  percentage and  plotted against the  concentration of 
RU28318 used in the experiment. 
feline  kidney  cells  is  mediated  by  the  mineralocorticoid 
receptor. 
The Induction of  MMTV LTR Transcription 
by Aldosterone Requires No De Novo Protein Synthesis 
Cycloheximide, the protein synthesis inhibitor,  inhibits  the 
aldosterone-dependent  sodium  transport  in  renal  A6 cells 
(22). This suggests that this  action of aldosterone requires 
new protein synthesis.  We have studied the effect of cyclohex- 
imide on the aldosterone-induced MMTV LTR transcription 
in our feline renal cells (2C9) using the S1 nuclease mapping 
procedure to determine whether this  drug inhibits this  re- 
sponse too. 
The induction of MMTV LTR transcription by aldosterone 
in the absence of cycloheximide was rapid; occurring within 
30 min after hormone addition and reaching a maximum by 
3  h  (Fig.  3,  lanes  1-6).  The same kinetic of induction of 
MMTV LTR transcription by aldosterone was determined in 
2C9 cells  treated  with  cycloheximide (Fig.  3,  lanes 7-12). 
These experiments indicate that de novo protein synthesis is 
not required for the aldosterone induction of MMTV LTR 
transcription. As in the case of the induction of MMTV LTR 
transcription by glucocorticoids (8), progestin or androgen 
(5),  the  stimulation  of MMTV  LTR  transcription  by  al- 
dosterone  represents  a  genuine  primary  response  to  this 
hormone. 
Sequence Overlapping the HRE Mediate the 
Mineralocorticoid Induction of  MMTV LTR 
Transcription 
The HRE located between nucleotides -202 and -59 5' up- 
stream of the start of transcription at the MMTV LTR pro- 
moter, mediates the glucocorticoid (48),  progestin and an- 
Figure 3. De novo  protein synthesis is not required for the induction 
of MMTV LTR transcription of a chimaeric proviral construct in 
feline kidney cells. 2C9 cells, a cloned population of feline kidney 
cells stably transfected with a chimaeric MMTV proviral construct 
were cultured for 2 wk in DME supplemented with 3 % CCS and 
treated with 10  -7 M aldosterone in the absence (lanes 1-6) or pres- 
ence (lanes 7-12) of cycloheximide  (20 txg/ml). The cycioheximide 
was added to the cells 5 min before the addition of aldosterone. The 
cells were harvested at the indicated time (in hours) after hormone 
treatment and RNAs were extracted. 30 Ixg of RNA were used in 
S1  nuclease mapping experiments with the 2.l-kb  Ca II/Hpa II 
MMTV LTR fragment as probe (see Materials and Methods). The 
arrow indicates the start of transcription at the correctly initiated 
MMTV LTR promoter. M stands for labeled Hae III fragments of 
plasmid pBR322 used as marker. 
drogen  (5)  induction  of LTR transcription.  To  determine 
whether the HRE also plays a role in the aldosterone induc- 
tion of MMTV LTR transcription, we transiently transfected 
different MMTV LTR chimaeric constructs into the 2C9 fe- 
line kidney cells.  The transfected constructs were MMTV 
LTR 5'-deletion fragments linked to the bacterial chloram- 
phenicol acetyl transferase (CAT) gene in such a way that the 
MMTV LTR promoter drives the transcription of the CAT 
gene (Fig.  4 A). 
For technical  reasons,  we were unable to transfect 2C9 
cells cultured for a week in medium supplemented with 3 % 
CCS. To decrease the high basal activity of the MMTV LTR 
promoter in the absence of aldosterone, we cultured the 2C9 
cells in medium containing 10% FCS and treated them 24 h 
before transfection and all  through the transfection period 
and  thereafter  with  10  -6  M  RU28318.  Cells  treated  with 
hormone  received  10  -6  M  aldosterone  in  addition  to  the 
mineralocorticoid inhibitor.  This concentration of aldoster- 
one overcomes the inhibitory effect of the rather weak miner- 
alocorticoid antagonist RU28318. 
Different levels of CAT activity were measured in the ab- 
sence of hormone in the 2C9 cells transfected with the differ- 
ent MMTV LTR-CAT constructs (Fig.  4 B).  These differ- 
ences in CAT activity could be attributed to the presence of 
activator or repressor elements that we have identified  in the 
5' upstream region of the MMTV LTR (results  not shown). 
Regardless of what these elements are and how they func- 
tion, all the constructs with the exception of pGREOOCAT 
when transfected showed an aldosterone-induced CAT activ- 
ity of 3-7-fold (Fig. 4 B). As cells transfected with the pHC- 
wt construct showed an aldosterone induction of CAT activ- 
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quires sequences that overlap the HRE on the MMTV LTR. (A) The 
indicated MMTV LTR 5' deletions fragments were linked to the CAT 
gene in such a way that the MMTV LTR drives the transcription 
of the CAT gene.  The HRE (hatched box) contains the hormone 
receptor-binding sites (24, 28).  These constructs were transiently 
transfected into 2C9 cells and CAT activity was measured  in the 
presence and absence of aldosterone, dexamethasone and RU28318. 
The induction factors were derived from the averages of four inde- 
pendent transfection experiments with at least two different plasmid 
DNA preparations.  (B) CAT activity of the various MMTV LTR 
5' deletion constructs in cells treated with or without aldosterone. 
Ch stands for chloramphenicol and AcCh stands for the acetylated 
form of chloramphenicol.  CAT activity determination and the cal- 
culation of induction factors were all as previously described  (8). 
200-1xg protein from cellular extracts of the transfected cells were 
used for the CAT assay. (C) The construct pHCwt was transiently 
transfected into the 2C9 feline kidney cells and CAT activity was 
measured after the cells had been treated with aldosterone and/or 
RU28318.  CAT  activity  induced  by  10  -6  M  aldosterone  of the 
transfected pHCwt is inhibited by 10  -4 M of the mineralocorticoid 
antagonist RU28318. 200-1~g  protein from the transfected cells were 
used for the CAT assay. (D) The construct pHCwt was transiently 
transfected into the 2C9 feline kidney cells and treated with dexa- 
methasone and/or RU28318 and CAT activity was determined. CAT 
activity  induced  by  dexamethasone  (10  -6  M)  of the  transfected 
pHCwt  is  not  inhibited  by  the  mineralocorticoid  antagonist 
RU28318 (10  -4 M). 200-I,  tg protein from the transfected cells were 
used for the CAT assay. 
ity but not cells transfected with the construct pGREOOCAT, 
we concluded that the sequence (-237 to -73) missing in the 
pGREOOCAT construct  is  needed  for the aldosterone re- 
sponse.  This  sequence  overlaps the  HRE  (-202  to  -59) 
which is required for the induction of MMTV LTR transcrip- 
tion by other steroid hormones (5,  18). 
As concentrations of 10  -6 M aldosterone had to be used in 
the transient transfection experiments for an appreciable in- 
duction  of  CAT  activity  to  be  observed,  we  wondered 
whether the results of the CAT assay reflected a true miner- 
alocorticoid response. We therefore transfected the construct 
pHCwt into the 2C9 cells and treated the cells with either 
l0  -6  M  aldosterone  or  10  -6  M  dexamethasone.  Both  al- 
dosterone and dexamethasone induced  CAT activity in the 
transfected cells (Fig. 4, C and D). However the CAT activity 
induced by aldosterone as well as the basal level of CAT ac- 
tivity was drastically reduced by 0.1 mM of the mineralocor- 
ticoid antagonist RU28318  (Fig.  4  C).  This anti-hormone 
had  no effect on the dexamethasone-induced  CAT activity 
(Fig. 4 D). This indicates that aldosterone at the concentra- 
tion used in the transient transfection experiments mediated 
a  true mineralocorticoid response. 
Taken  together,  the  results  we  have  presented  identify 
nucleotides  -237  to  -73  that overlap the  HRE as the  se- 
quence  necessary  for  the  mineralocorticoid  induction  of 
MMTV LTR transcription. 
Discussion 
Little progress has been achieved in general on studies of the 
effect of mineralocorticoids on gene expression for a number 
of reasons. Firstly, so few cells are targets for mineralocorti- 
coid action that an extensive search for the appropriate cells 
and marker genes has to be pursued. Secondly, even among 
the target cells for mineralocorticoids, the determination of 
the levels of mineralocorticoid receptor remains a problem 
as no true mineralocorticoid ligands are available. The ever 
popular mineralocorticoid, aldosterone, has a high affinity 
for its own receptor and some affinity for the glucocorticoid 
receptor (19). A possibility of blocking off these glucocorti- 
coid-binding sites by glucocorticosteroids has met with little 
success.  Most  glucocorticoids  including  the  potent  dexa- 
methasone have some affinity for the mineralocorticoid re- 
ceptor (19) and are therefore not suitable for use as effective 
blockers. Recently a new synthetic glucocorticoid (RU28362) 
has been developed that has a high affinity for the glucocorti- 
coid receptor and virtually no affinity for the mineralocorti- 
coid receptor (2). We have used this "pure" glucocorticoid to- 
gether  with  labeled  aldosterone  to  show  that  in  cytosolic 
extracts of a cloned population of cat kidney cells (2C9 cells) 
(23) aldosterone binds exclusively to the mineralocorticoid 
receptor. 
We have also demonstrated that the mineralocorticoid, al- 
dosterone  induces  the  transcription  of transfected MMTV 
LTR chimaeric constructs in these 2C9 cells through its own 
receptor. These studies were made possible by the availabil- 
ity of a mineralocorticoid antagonist RU28318 (21) that reacts 
specifically with the mineralocorticoid receptor and inhibits 
a true mineralocorticoid response~ The induction of MMTV 
LTR transcription by aldosterone follows a similar mode of 
action as the other steroid hormones that induce the tran- 
scription of this DNA (5, 8). The induction is rapid and re- 
quires  no  new protein  synthesis.  Above all,  the  DNA se- 
quences on the LTR that mediate the aldosterone response 
overlap the HRE at the MMTV LTR promoter required for 
the response to other steroids (5,  18). 
The  HRE  of the  MMTV  LTR  contains  four  receptor- 
binding  sites with the hexanucleotide core 5'-TGTTCT-Y. 
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progesterone receptors (24,  28).  Sequence analyses of the 
cDNAs for these two receptors show that their DNA binding 
domains have  a high degree of sequence homology  (85 % 
amino acid sequence homology) (11, 12). This might explain 
why both receptors bind to identical sequences on the HRE. 
Our finding that aldosterone requires sequences on the HRE 
for the induction of MMTV LTR transcription  makes it very 
likely that the aldosterone receptor also binds to sequences 
on the HRE and possesses a DNA binding domain highly ho- 
mologous  to  identical  domains  in  the  glucocorticoid  and 
progesterone  receptors.  Indeed  recent  sequencing  of the 
cloned human mineralocorticoid receptor has shown that the 
DNA-binding domain of this receptor shares  a high degree 
of relatedness to the DNA binding domains of the glucocorti- 
coid and progesterone receptors (94 and 90% amino acid se- 
quence identity)  (1). 
In the  mouse,  the  transcription  of MMTV  proviral  se- 
quences occurs predominantly in mammary gland ceils (26) 
where these sequences have been implicated in the develop- 
ment of mammary carcinomas (9). Mammary cells are usu- 
ally  not targets  for mineralocorticoid action,  although the 
presence of mineralocorticoid receptors in some neoplastic 
breast lesions has been reported (13). The role of these recep- 
tors in mammary tumor cells has been speculated to be the 
control of ionic movement throughout  the mammary epithe- 
lial structure (13). If this is the case, then the mineralocorti- 
coid induction of MMTV  LTR transcription  that we have 
demonstrated here would be an important process in murine 
mammary tumorigenesis. 
Recently exogenous  MMTV  proviruses have  been iden- 
tified in renal  cells of the mouse (30).  Although the LTR 
of these proviruses differ from the mammary cell MMTV 
LTR in the U3 region, the HREs of both LTRs are intact. The 
HRE in the renal cell MMTV LTR mediates glucocorticoid 
response (30).  From our results, we would predict that al- 
dosterone  would  also  stimulate  the  transcription  of this 
MMTV LTR in the renal cells through the same HRE. The 
aldosterone induction of MMTV LTR transcription  in renal 
ceils may be an important process as MMTV expression in 
these cells has been correlated with the development of renal 
adenocarcinomas (30). 
We thank D. Henderson (Berlin) for his advice on how to go about studying 
the mineralocorticoid action and Roussel Uclaf (Romainvitle) for supplying 
us with RU28318 and RU28362.  We also thank J. Nowock (Hamburg)  for 
the gift of the construct pGREOOCAT. We are grateful  to H. Ponta (Karls- 
ruhe) for helpful  discussions. 
Received for publication 22 December 1987, and in revised form  10 Febru- 
ary 1988. 
References 
1. Arriza,  J.  L., C. Weinberger,  G. Cerelli, T.  M. Glaser,  B. L. Hendelin, 
D. E.  Housmann,  and R.  M.  Evans.  1987. Cloning  of human miner- 
alocorticoid receptor complementary DNA: structural and functional kin- 
ship with the glucocorticoid  receptor.  Science (Wash. DC). 237:268- 
275. 
2. Beato, M., and P. Feigelson.  1972. Glucocorticoid-binding proteins of rat 
liver cytosol. J.  Biol. Chem. 247:7890-7896. 
3. Beato, M., C. Scheidereit, P. Kranter, D. yon der Ahe, S. Janich, A. C. B. 
Cato, G. Suske, H. M. Westpbal.  1985. The regulatory elements in ste- 
roid hormone inducible genes: structure and evolution of DNA sequences 
recognized by steroid hormone receptors. In Chromosomal Proteins and 
Gene Expression. G. R. Reeck, G. A. Goodwin, and P. Puigdomenech, 
editors.  Plenum Press,  New York.  121-141. 
4.  Cato, A. C. B., R. Miksicek, G. Schiitz, J. Arnemann, and M. Beam. 1986. 
The hormone regulatory element of mouse mammary tumor virus medi- 
ates  progesterone  induction.  EMBO  (Eur. Mol. Biol. Organ.)  J.  5: 
2237-2240. 
5. Cato, A. C. B., D. Henderson, and H. Ponta. 1987. The hormone response 
element of  the mouse mmmna~ tumor virus DNA mediates the progestin 
and androgen induction of transcription in the proviral long terminal re- 
peat region.  EMBO  (Eur. Mol. Biol. Organ.) J.  6:363-368. 
6. Crandell, R. A., C. G. Fabricant, and W. A. Nelson-Rees. 1973. Develop- 
ment, characterization and viral susceptibility of a feline (Felis catus) re- 
nal cell Iine (CRb'K). In Vitro. 9:176--185. 
7. Funder,  J.  W.  1987. Adrenal  steroids:  New  answers,  new  questions. 
Science  (Wash. DC).  237:236-237. 
8. Groner, B., N. E. Hynes, U. Rahmsdorf, and H. Ponta.  1983. Transcrip- 
tion initiation of transfected mammary tumor virus LTR DNA is regu- 
lated by glucocorticoid hormones.  Nucl. Acids.  Res.  11:4713-4725. 
9. Hilgers, J., and P. Bentvelzen. 1979. Interactions between viral and genetic 
factors in murine mammary cells. Adv.  Cancer Res. 26:143-195. 
10.  Hynes, N. E., A. van Ooyen, N. Kennedy, P. Herrlich,  H. Ponta, and B. 
Groner.  1983. Subfragments of the large  terminal repeat cause gluco- 
corticoid-responsive expression of mouse manunary tumor virus and of 
an adjacent gene. Proc.  Natl. Acad.  Sci. USA. 80:3637-3641. 
11. Jeltsch, J.  M., Z.  Krozowski,  C.  Quirin-Stricker,  H. Grnnemeyer,  R. J. 
Simpson, J.  M.  Gamier, A. Krust,  F. Jacob,  and P.  Charnbon.  1986. 
Cloning  of the chicken  progesterone  receptor.  Proc.  Natl. Acad. Sci. 
USA. 83:5424-5428. 
12. Loosfelt, H., M. Atger, M. Misrachi, A. Gniochon-Mantel, C. Meriel, F. 
Logeat, R. Benarous, and E. Milgrom.  1986. Cloning and sequence anal- 
ysis of rabbit progesterone-receptor  complementary DNA.  Proc.  Natl. 
Acad.  Sci. USA. 83:9045-9049. 
13.  Martin, P. M., P. H. Rolland, and J.-P.  Raynand.  1981. Macromolecular 
binding of dexamethasone as evidence for the presence of mineralocorti- 
coid receptor in human breast cancer.  Cancer Res.  44:1222-1226. 
14. Miksicek,  R.,  U.  Borgmeyer,  and J.  Nowock.  1987. Interaction  of the 
TGCd=A-binding protein with upstream sequences is required for efficient 
transcription of mouse mammary turnout virus. EMBO (Fur. Mol. Biol. 
Organ.) J.  6:1355-1360. 
15. Monguilewsky,  M.,  and  J.-P.  Raynaud.  1980.  Evidence  for a  specific 
mineralocorticoid receptor in rat pituitary and brain. J. Steroid Biochem. 
12:309-314. 
16. Ott,  M.-O., L. Sperling,  P.  Herbomel,  M.  Yaniv, and M. Weiss.  1984. 
Tissue specific expression is conferred by a sequence from the 5'-end of 
the rat albumin gene. EMBO (Eur. Mol. Biol. Organ.) J.  3:2505-2510. 
17. Payvar, F., D. DeFranco, G. L. Firestone, B. Edgar, O. Wrange, S. Okret, 
J. A. Gustafsson, and K. R. Yamamoto. 1983. Sequence-specific binding 
of glucocorticoid receptor to MTV DNA at sites within and upstream of 
the transcribed  region.  Cell. 35:381-392. 
18. Ponta,  H., N. Kennedy, P.  Skroch,  N.  E. Hynes,  and B. Groner.  1985. 
Hormonal response region in the mouse mammary tumor virus long ter- 
minal repeat region can be dissociated from the proviral promoter and has 
enhancer properties.  Proc. Natl. Acad.  Sci. USA. 82:1020-1024. 
19. Raynaud, J.-P., and T. Ojasoo.  1983. The relevance of structure-affinity 
relationships in the study of steroid hormone action. In Steroid Hormone 
Receptors:  Structure and Function.  H. Eriksson  and J.  A. Gustafsson, 
editors.  Elsevier Science Publishers.  B. V.  141-170. 
20.  Raynand, J. P., T. Ojasoo, A. Jouquey, M. Moguilewsky, and G. Teutsch. 
1984. Probes for steroid receptors.  In Endocrinology.  F. Labrie and L. 
Proulx,  editors.  Elsevier Science Publishers.  B. V. 533-536. 
21.  Raynand, J.-P., M. Fortin,  P. Hunt, T. Ojasoo, J.-C.  Dor~, E. Surcouf, 
and J. P. Mornon.  1986. Approaches to drug development using recep- 
tors in Biology and Medicine. A. M. Gotto Jr. and B. W. O'Malley, edi- 
tors.  Raven Press.  New York.  63-77. 
22.  Rossier, B. C., M. P. Paccolat, F. Verrey, J. P. Kraehenbithl, and K, Geer- 
ing.  1985. Mechanism of action of aldosterone:  a pleiotropic response. 
Hormones and cell regulation 9:209-225. 
23.  Salmons,  B.,  B.  Groner,  C.  M.  Calberg-Bacq,  and  H.  Ponta.  1985. 
Production  of mouse  mammary  tumour virus upon  transfection  of a 
recombinant proviral DNA into cultured cells.  Virology. 144:101-114. 
24.  Scheidereit, C., S. Geisse, H. M. Westphal, and M. Beato. 1983. The glu- 
cocorticoid receptor binds to defined nucleotide sequences near the pro- 
moter of mouse mammary tumor virus.  Nature  (Lond.).  304:749-752. 
25.  Southern, P. J., and P. Berg.  1982. Transformation of mammalian cells to 
antibiotic resistance with a bacterial gene under control of the SV40 early 
region promoter.  J.  Mol. Appl.  Genet. 1:327-341. 
26. Varmus, H. E., N. Quintrell, E. Medeiros, R. C. Bishop, R. C. Nowinski, 
and N. H. Sarkar.  1973. Transcription of mouse manunary tumour virus 
genes in tissues from high and low incidence mouse strains. J. Mol. Biol. 
79:663-679. 
27.  Verrey,  F., E. Sehaerer,  P. Zoerkler,  M. P.  Paccolat, K. Geering, J.  P. 
Kraehenbiihl,  and B.  C.  Rossier.  1987. Regulation by aldosterone  of 
Na  +,  K+-ATPase mRNAs,  protein  synthesis  and  sodium  transport  in 
cultured kidney cells. J.  Cell Biol. 104:1231-1237. 
28. Von der Ahe, D., S. Janich, C. Scheidereit, R. Renkawitz, G. Schiitz, and 
M. Beato. 1985. Glucocorticoid and progesterone receptors bind to the 
same sites in two hormonally regulated promoters. Nature (Lond.). 313: 
The Journal of Cell Biology, Volume  106, 1988  2124 706-709. 
29. Weaver, R. F., and C. Weissmann. 1979. Mapping of RNA by a modifica- 
tion of the Berk-Sharp procedure: the 5' termini of 15S I~-globin mRNA 
precursor and mature  10S  I~-globin mRNA have identical  map coor- 
dinates. Nucl. Acids Res. 7:1175-1193. 
30. Wellinger, R. J., M. Garcia, A. Vessaz, H. Diggelmann. 1986. Exogenous 
mouse mammary turnout virus proviral DNA isolated from a kidney ade- 
nocarcinoma cell line contains alterations in the U3 region of the long ter- 
minal repeat. J.  Virol.  60:1-11. 
31. Westley, B., and H. Rochefort. 1980. A secreted glycoprotein induced by 
estrogen in human breast cancer cell line. Cell.  20:353-362. 
32. Yamamoto, K.  1985.  Steroid receptor regulated transcription of specific 
genes and gene networks. Annu.  Rev.  Genet.  19:209-252. 
Cato and Weinmann Aldosterone Regulation  of MMTV Transcription  2125 